{"id":2646,"date":"2019-10-30T19:07:31","date_gmt":"2019-10-30T23:07:31","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/hunter-shkolnik-quoted-on-tevas-agreement-proposal\/"},"modified":"2022-06-27T02:34:24","modified_gmt":"2022-06-27T06:34:24","slug":"%e3%83%8f%e3%83%b3%e3%82%bf%e3%83%bc-shkolnik-tevas-agreement-proposal%e3%81%ae%e5%bc%95%e7%94%a8","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/ja\/%e7%99%bd%e3%81%84%e7%b4%99\/%e3%83%8f%e3%83%b3%e3%82%bf%e3%83%bc-shkolnik-tevas-agreement-proposal%e3%81%ae%e5%bc%95%e7%94%a8\/","title":{"rendered":"Hunter Shkolnik \u304c Teva \u306e\u5951\u7d04\u63d0\u6848\u306b\u5f15\u7528"},"content":{"rendered":"<p>J&amp;J, Teva offer a massive\u00a0$48B combined to wrap opioid suits, but not all plaintiffs are on board<\/p>\n<p>With reports like that in the ether, it\u2019s no wonder some plaintiffs are\u00a0reticent to sign on to the \u201cframework deal\u201d that includes the\u00a0Teva and J&amp;J offers, along with\u00a0additional deals with three drug distributors.<\/p>\n<p>Officials in at least four states have\u00a0pushed back\u00a0against the proposal, arguing that Teva\u2019s agreement is \u201covervalued to make the settlement look better,\u201d Hunter Shkolnik, a lawyer on a plaintiffs executive committee, told Reuters.<\/p>","protected":false},"excerpt":{"rendered":"<p>J&amp;J\u3001Teva \u306f\u3001\u30aa\u30d4\u30aa\u30a4\u30c9 \u30b9\u30fc\u30c4\u3092\u5305\u3080\u305f\u3081\u306b\u7d44\u307f\u5408\u308f\u3055\u308c\u305f\u5927\u898f\u6a21\u306a $48B \u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u3059\u3079\u3066\u306e\u539f\u544a\u304c\u53c2\u52a0\u3057\u3066\u3044\u308b\u308f\u3051\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>","protected":false},"featured_media":0,"menu_order":237,"template":"","whitepaper_category":[57,75,98,253,254],"whitepaper-source":[326],"class_list":["post-2646","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-hunter-shkolnik","whitepaper_category-opioids-litigation","whitepaper_category-ohio-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-fiercepharma-com"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepapers\/2646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepapers\/2646\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/media?parent=2646"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepaper_category?post=2646"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/ja\/wp-json\/wp\/v2\/whitepaper-source?post=2646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}